- Home
- ABT vs BTI Comparison
ABT vs BTI Comparison
Compare ABT & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABT | BTI |
|---|---|---|
| Founded | 1888 | 1902 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.9B | 127.8B |
| IPO Year | 2006 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ABT | BTI |
|---|---|---|
| Price | $109.74 | $56.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 2 |
| Target Price | ★ $130.90 | $62.00 |
| AVG Volume (30 Days) | ★ 8.8M | 4.0M |
| Earning Date | 04-16-2026 | 02-12-2026 |
| Dividend Yield | 2.76% | ★ 5.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $44,328,000,000.00 | N/A |
| Revenue This Year | $10.75 | $3.72 |
| Revenue Next Year | $8.10 | $3.56 |
| P/E Ratio | $179.90 | ★ $12.53 |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $81.97 | $49.88 |
| 52 Week High | $137.49 | $67.30 |
Technical Indicators
Market Signals| Indicator | ABT | BTI |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 36.37 |
| Support Level | $105.27 | $56.20 |
| Resistance Level | $111.89 | $62.93 |
| Average True Range (ATR) | 2.41 | 1.02 |
| MACD | 0.03 | -0.47 |
| Stochastic Oscillator | 83.09 | 4.49 |
Price Performance
Historical ComparisonAbout ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
About BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.